← FDA Warning Letters
Profounda, Inc.
FDA Warning Letter · 2023-03-14 · Division of Pharmaceutical Quality Operations II
Letter
- Company
- Profounda, Inc.
- Posted Date
- 2023-03-14
- Letter Issue Date
- 2023-02-01
- Issuing Office
- Division of Pharmaceutical Quality Operations II
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown